Medicare Panel Laments Holes In Ventricular Assist Device Evidence Base
This article was originally published in The Gray Sheet
Executive Summary
CMS does not currently have a national coverage determination process open on ventricular assist devices for heart failure, though the agency may open a new one, an agency official said.
You may also be interested in...
CMS Fields Many Suggestions And Criticisms On Proposed VAD Policy
Several stakeholders are still pushing CMS to recognize “bridge-to-decision” heart failure patients who may eventually be suitable for a heart transplant but are not so at the time they receive a ventricular assist device.
CMS Fields Many Suggestions And Criticisms On Proposed VAD Policy
Several stakeholders are still pushing CMS to recognize “bridge-to-decision” heart failure patients who may eventually be suitable for a heart transplant but are not so at the time they receive a ventricular assist device.
Heart Surgeons Want CMS To Rethink Indications For LVADs, Recognize Transplant “Bridge-To-Decision” Patients
The current two-indication system for approving and covering left-ventricular assist devices does not reflect the reality of heart failure patients receiving these devices, according to transplant surgeons.